Availability of data and material
The data and materials for all patients are available.
Code availability
N/A.
References
Nadar R, Shaw N (2020) Investigation and management of hypocalcaemia. Arch Dis Child 105:399–405. https://doi.org/10.1136/archdischild-2019-317482
Yamamoto M, Akatsu T, Nagase T, Ogata E (2000) Comparison of hypocalcemic hypercalciuria between patients with idiopathic hypoparathyroidism and those with gain-of-function mutations in the calcium-sensing receptor: is it possible to differentiate the two disorders? J Clin Endocrinol Metab 85:4583–4591. https://doi.org/10.1210/jcem.85.12.7035
Hussain A, Atlani M, Goyal A, Khurana AK (2021) Type-5 Bartter syndrome presenting with metabolic seizure in adulthood. BMJ Case Rep 14:e235349. https://doi.org/10.1136/bcr-2020-235349
Bianchetti MG, Simonetti GD, Lava SAG, Bettinelli A (2016) Differential diagnosis and management of fluid electrolyte and acid base disorders. In: Schaefer F, Geary DF (eds) Comprehensive Pediatric Nephrology, 2nd edn. Springer, Berlin, Germany, pp 863–876
Hannan FM, Nesbit MA, Zhang C, Cranston T et al (2012) Identification of 70 calcium-sensing receptor mutations in hyper- and hypo-calcaemic patients: evidence for clustering of extracellular domain mutations at calcium-binding sites. Hum Mol Genet 21:2768–2778. https://doi.org/10.1093/hmg/dds105
Egbuna OI, Brown EM (2008) Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutations. Best Pract Res Clin Rheumatol 22:129–148. https://doi.org/10.1016/j.berh.2007.11.006
Roszko KL, Bi RD, Mannstadt M (2016) Autosomal dominant hypocalcemia (hypoparathyroidism) types 1 and 2. Front Physiol 7:458. https://doi.org/10.3389/fphys.2016.00458
Maio SD, Soliman AT, Sanctis VD (2018) Current treatment of hypoparathyroidism: theory versus reality waiting guidelines for children and adolescents. Acta Biomed 89:122–131 https://doi.org/10.23750/abm.v89i1.7118
Lienhardt A, Garabedian M, Bai M, Sinding C, Zhang Z, Lagarde JP et al (2001) Hypocalcemia with activating CaSR Mutations. J Clin Endocrinol Metab 86:5313–5323
Vahe C, Benomar K, Espiard S (2017) Diseases associated with calcium-sensing receptor. Orphanet J Rare Dis 12:19. https://doi.org/10.1186/s13023-017-0570-z
Mayr B, Schnabel D, Dörr HG, Schöfl C (2016) Genetics in endocrinology: gain and loss of function mutations of the calcium-sensing receptor and associated proteins: current treatment concepts. Eur J Endocrinol 174:189–208. https://doi.org/10.1530/EJE-15-102
Mannstadt M, Bilezikian JP, Thakker RV, HannanFM CBL, Rejnmark L (2017) Hypoparathyroidism. Nat Rev Dis Primer 3:17055
Bollerslev J, Rejnmark L, Marcocci C, Schoback DM, Sitges-Serra A, Biesen WV, Dekkers OM (2015) European Society of Endocrinology Clinical Guideline: treatment of chronic hypoparathyroidism in adults. Eur J Endocrinol 173:G1–G20
BrandiML BJP, Shoback D, Bouillon R, Clarke BL, Thakker RV, Khan AA, Potts JT (2016) Management of hypoparathyroidism: summary statement and guidelines. J Clin Endocrinol Metab 101:2273–2283
Hannan FM, Kallay E, ChangW BML, Thakkar RV (2018) The calcium-sensing receptor in physiology and in calcitropic and noncalcitropic diseases. Nat Rev Endocrinol 15:33–51
Nesbit MA, Hannan FM, Howles SA, Babinsky VN, Head RA, Cranston T et al (2013) Mutations affecting G-protein subunit alpha-11 in hypercalcemia and hypocalcemia. N Engl J Med 368:2476–2486
Rossi GC, Patterson AL, McGregor AL, Wheless JW (2019) Intractable generalized epilepsy and autosomal dominant hypocalcemia: a case report. Child Neurol Open 6:2329048X19876199
Watanabe S, Fukumoto S, Chang H, Takeuchi Y, Hasegawa Y, Okazaki R, Chikatsu N, Fujita T (2002) Association between activating mutations of calcium sensing receptor and Bartter’s syndrome. Lancet 360:692–694
Regala J, Cavaco B, Domingues R, Limbert C, Lopes L (2015) Novel mutation in the CASR gene (p.leu123ser) in a case of autosomal dominant hypocalcemia. J Pediatr Genet 4:29–33. https://doi.org/10.1055/s-0035-1554979
Burren CP, Curley A, Christie P, Rodda CP, Thakkar RV (2005) A family with autosomal dominant hypocalcaemia with hypercalciuria (ADHH): mutational analysis, phenotypic variability and treatment challenges. J Pediatr Endocrinol Metab 18:689
Author information
Authors and Affiliations
Contributions
All the authors contributed to data collection and management of patients and correction of the manuscript. Prof Abhijeet conceptualized and designed the study, coordinated and supervised data collection, and critically reviewed the manuscript for important intellectual content. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.
Corresponding author
Ethics declarations
Ethics approval
Institutional Ethics Committee approved the study.
Consent to participate
Informed consent was obtained from all individual participants included in the study.
Consent for publication
Informed consent was obtained for publication.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This refers to the article that can be found at http://dx.doi.org/10.1007/s00467-021-05272-9.
Rights and permissions
About this article
Cite this article
Kakkar, V., Pandit, K., Yadav, M. et al. Recurrent hypocalcemic tetany presenting to the emergency room: Answers. Pediatr Nephrol 37, 581–584 (2022). https://doi.org/10.1007/s00467-021-05283-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-021-05283-6